NEMIS Technologies Ltd. closes CHF 7.75 million Series A Funding Round Investment will enable the Swiss Biotech Startup to further scale up its production, boost product development and pursue its ambitious internationalization strategy to meet increasing global demand Dübendorf, Zurich – NEMIS Technologies Ltd., amongst the Top 15 Swiss Biotech Startups of 2021, announces the […]

CAMBRIDGE, UK – Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional […]

Automated Liquid Handling Company Earns Investment to Drive Commercial Growth BOSTON — Avidien announced today a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. Avidien CEO and Founder Rich Cote said, “The partnership with BroadOak is exciting and ushers in […]

Nina Capital, APEX Medical and Cambridge Enterprise invest in transformational open-source data technology – to deliver precision medicine at scale University of Cambridge technology spin-out Zetta Genomics announces that is has raised £2.5 million in new seed funding. The successful round secures leading global Venture Capital (VC) investment in the company’s XetaBase platform – a […]

VIENNA — Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors. Existing investors IST cube and tecnet equity […]

Led by Inovia Capital and TCV, funding brings total investment to $123 million and will expedite expansion of machine learning technology used in 16 of the top 20 pharmaceutical companies Toronto, CANADA — BenchSci, a global leader in machine learning applications for novel medicine development, today announced a $63 million Series C (US $50 Million) […]

The funding will drive international deployment of the company’s next generation genomic analysis platform to enable personalized medicine in cancers as well as rare and hereditary diseases. Montpellier – SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine today announced a Series A funding round of €20M.  The round, led by Omnes, Merieux […]

Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions Dr. Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Board of Directors Following Close; Alex Kim, Former President of Milliken & Company’s Healthcare Division, to Assume Role of COO Eli Casdin, CIO […]

Pioneers in observing single molecules in living cells Funds will be used to build a product portfolio that harnesses the company’s innovative technology to unlock new possibilities in therapeutic and diagnostic development as well as basic life science research The company expands its management team and board of directors with the addition of several industry […]